What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Radiation therapy
Howard D. Thames focuses on Radiation therapy, Nuclear medicine, Surgery, Internal medicine and Urology.
His Radiation therapy research incorporates themes from Survival analysis, Prostate, Prostate cancer and Confidence interval.
His biological study spans a wide range of topics, including Hyperfractionation, Clonogenic assay, Radiosensitivity and Dose–response relationship.
His studies in Internal medicine integrate themes in fields like Medical physics and Oncology.
The various areas that he examines in his Oncology study include Radiation tolerance, Cancer, Tumor control and Mammary gland.
His study in Urology is interdisciplinary in nature, drawing from both Preoperative radiation, Accelerated fractionation and Doubling time.
His most cited work include:
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference (1831 citations)
- Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationships (748 citations)
- Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue (554 citations)
What are the main themes of his work throughout his whole career to date?
Howard D. Thames mostly deals with Radiation therapy, Internal medicine, Nuclear medicine, Oncology and Surgery.
His Radiation therapy study combines topics in areas such as Cancer, Prostate cancer, Urology, Pathology and Proportional hazards model.
Within one scientific family, Howard D. Thames focuses on topics pertaining to Cancer research under Pathology, and may sometimes address concerns connected to Clonogenic assay.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Endocrinology.
His Nuclear medicine course of study focuses on Irradiation and Molecular biology.
His work carried out in the field of Surgery brings together such families of science as Multivariate analysis and Radiology.
He most often published in these fields:
- Radiation therapy (35.80%)
- Internal medicine (29.26%)
- Nuclear medicine (27.84%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (29.26%)
- Oncology (22.73%)
- Radiation therapy (35.80%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Oncology, Radiation therapy, Nuclear medicine and Prostate cancer.
The study incorporates disciplines such as Gastroenterology and Radiology in addition to Internal medicine.
His Oncology research includes themes of Head and neck squamous-cell carcinoma, Breast cancer, Personalized oncology and Breast-conserving surgery.
Howard D. Thames has researched Radiation therapy in several fields, including Stage, Celecoxib, Dose–response relationship and Pathology.
Howard D. Thames interconnects Dose escalation, Dose fractionation, Proportional hazards model and Fractionated irradiation, Irradiation in the investigation of issues within Nuclear medicine.
His study focuses on the intersection of Prostate cancer and fields such as Brachytherapy with connections in the field of Whole Breast Irradiation, Medical physics and Magnetic resonance imaging.
Between 2011 and 2021, his most popular works were:
- Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis (120 citations)
- HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) (97 citations)
- Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG (68 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Radiation therapy
His scientific interests lie mostly in Nuclear medicine, Radiation therapy, Internal medicine, Oncology and Head and neck squamous-cell carcinoma.
He combines subjects such as Experimental model, Dose level and Dose distribution with his study of Nuclear medicine.
His Ablative case study, which is part of a larger body of work in Radiation therapy, is frequently linked to In patient, bridging the gap between disciplines.
His Internal medicine study frequently links to other fields, such as Gastroenterology.
His Oncology research includes elements of Hematology, Biopsy, Randomized controlled trial and Radiation sensitivity.
The concepts of his Head and neck squamous-cell carcinoma study are interwoven with issues in Clinical endpoint, Radiosensitivity and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
